Nerve News and Research

RSS

Researchers identify new therapeutic approach for stroke treatment

For the first time, research led by Youming Lu, PhD, MD, Professor of Neurology and Neuroscience at LSU Health Sciences Center New Orleans School of Medicine, has identified a novel mechanism that may trigger brain damage during stroke and identified a therapeutic approach to block it.

22 Jan 2010

Findings may aid in developing therapeutic drugs for stroke and other neurodegenerative diseases

Biomedical scientists from the University of Central Florida and Louisiana State University have identified a way to block a "cell death signal" that they believe triggers brain damage during strokes.

22 Jan 2010

Fourth-quarter and fiscal year 2009 results announced by Somanetics

Somanetics Corporation today reported financial results for the fourth fiscal quarter and year ended November 30, 2009.

21 Jan 2010

BioNumerik Pharmaceuticals commences patient treatment in Tavocept Phase III trial

BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.

21 Jan 2010

MaMayo Clinic experts available to discuss health issues and concerns related to Olympic Games

Mayo Clinic's medical experts are sources of in-depth expertise and commentary about health issues and background related to the Olympic Games and Olympians. Below is a sampling of Mayo Clinic experts available to discuss numerous topics related to the Olympic Games, including concussions, performance enhancing drugs, sports psychology, joint injuries, etc. Mayo has satellite capability for broadcast requests.

21 Jan 2010

Aetna and Walgreens collaborate to educate people on taking adequate levels of Vitamin D

Aetna (NYSE: AET) and Walgreens announced today that they have joined forces to educate people about the need to take in adequate levels of Vitamin D. The two organizations are working with United Way of the Midlands on a Vitamin D giveaway program being piloted in Richland and Lexington counties in South Carolina.

21 Jan 2010

Maturation disorders of nerve terminals may trigger autism

For brain cells to communicate, the contacts to each other must function. The protein molecule neuroligin-1 plays an important role in this as it stimulates the necessary maturation processes at the contact sites (synapses) of the nerves.

21 Jan 2010

Taking opioids long term could hold small risk of addition

Coping with chronic non-cancer pain is a way of life for millions of Americans. Unfortunately, many older adults, in particular, hesitate to take opioids — a kind of narcotic — for fear of addiction. However, a new review finds that taking opioids long term is associated with clinically significant pain relief in some patients with a very small risk of addition.

20 Jan 2010

New method for diagnosing post-traumatic stress disorder

Researchers at the University of Minnesota and Minneapolis VA Medical Center have identified a biological marker in the brains of those exhibiting post-traumatic stress disorder (PTSD).

20 Jan 2010

Use of braces in adolescent idiopathic scoliosis is still an area of controversy

The use of braces to correct excessive curvature of the spine, or scoliosis, in adolescents is still an area of controversy — and is likely to remain that way until there is better evidence, concludes a new review of published research. Although some evidence points toward a benefit from using braces, research has failed to prove definitively that they work.

20 Jan 2010

Diamyd Medical executes share split

Diamyd Medical announces today that the company executes a 2:1 division of shares (i.e. a split), meaning that each share is divided into two shares of the same class.

20 Jan 2010

HSF1A stimulates more protein chaperones and reduces protein misfolding

Scientists at Duke University Medical Center have found some compounds that improve a cell's ability to properly "fold" proteins and could lead to promising drugs for degenerative nerve diseases, including Huntington's disease, Alzheimer's disease and Parkinson's disease.

20 Jan 2010

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the “RNA Silencing: Mechanism, Biology, and Application” Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam’s therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington’s disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

20 Jan 2010

The Methodist Hospital initiates program on nanotechnology in orthopedics and spine surgery

A new research program at The Methodist Hospital in Houston is the nation's first dedicated solely to advancing nanotechnology in orthopedics and spine surgery.

19 Jan 2010

Voice abnormalities in cochlear implants will improve over time, says study

Children with cochlear implants in both ears appear to have difficulty controlling the loudness and pitch of their voices, but these measures improve over time, according to a report in the January issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals.

19 Jan 2010

Nerve News and Research

Researchers identify new therapeutic approach for stroke treatment

Findings may aid in developing therapeutic drugs for stroke and other neurodegenerative diseases

Fourth-quarter and fiscal year 2009 results announced by Somanetics

BioNumerik Pharmaceuticals commences patient treatment in Tavocept Phase III trial

MaMayo Clinic experts available to discuss health issues and concerns related to Olympic Games

Aetna and Walgreens collaborate to educate people on taking adequate levels of Vitamin D

Maturation disorders of nerve terminals may trigger autism

Taking opioids long term could hold small risk of addition

New method for diagnosing post-traumatic stress disorder

Use of braces in adolescent idiopathic scoliosis is still an area of controversy

Diamyd Medical executes share split

HSF1A stimulates more protein chaperones and reduces protein misfolding

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

The Methodist Hospital initiates program on nanotechnology in orthopedics and spine surgery

Voice abnormalities in cochlear implants will improve over time, says study

Smoking diabetics more likely to have a heart attack

Auditory feedback pathway in the brain linked to learned vocal control identified

NIH awards IU School of Optometry $2.35M for glaucoma research

Down syndrome and Alzheimer's disease are the same

UCL scientists: Simple eye test can help detect and diagnose major neurological diseases

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News